The changes in MLD from six to @ months in the target lesions were significantly lower in the rosuvastatin group than in the non-statin group among the patients treated with drug-eluting stents ( -@ @ mm vs. -@ @ mm , p = @ ) versus those treated with bare-metal stents ( -@ @ mm vs. -@ @ mm , p = @ ) .